Ultrasound Responsive Smart Implantable Hydrogels for Targeted Delivery of Drugs: Reviewing Current Practices

Over the last two decades, the process of delivering therapeutic drugs to a patient with a controlled release profile has been a significant focus of drug delivery research.Scientists have given tremendous attention to ultrasound-responsive hydrogels for several decades.These smart nanosystems are more applicable than other stimuli-responsive drug delivery vehicles (ie UV-, pH-and thermal-, responsive materials) because they enable more efficient targeted treatment via relatively non-invasive means.Ultrasound (US) is capable of safely transporting energy through opaque and complex media with minimal loss of energy.It is capable of being localized to smaller regions and coupled to systems operating at various time scales.However, the properties enabling the US to propagate effectively in materials also make it very difficult to transform acoustic energy into other forms that may be used.Recent research from a variety of domains has attempted to deal with this issue, proving that ultrasonic effects can be used to control chemical and physical systems with remarkable specificity.By obviating the need for multiple intravenous injections, implantable US responsive hydrogel systems can enhance the quality of life for patients who undergo treatment with a varied dosage regimen.Ideally, the ease of selfdosing in these systems would lead to increased patient compliance with a particular therapy as well.However, excessive literature has been reported based on implanted US responsive hydrogel in various fields, but there is no comprehensive review article showing the strategies to control drug delivery profile.So, this review was aimed at discussing the current strategies for controlling and targeting drug delivery profiles using implantable hydrogel systems.